Europe’s Open-Border Dilemma: Is Schengen a Success?

{
  "authors": [
    "Marc Pierini"
  ],
  "type": "legacyinthemedia",
  "centerAffiliationAll": "dc",
  "centers": [
    "Carnegie Endowment for International Peace",
    "Carnegie Europe"
  ],
  "collections": [
    "EU Integration and Enlargement"
  ],
  "englishNewsletterAll": "ctw",
  "nonEnglishNewsletterAll": "",
  "primaryCenter": "Carnegie Europe",
  "programAffiliation": "EP",
  "programs": [
    "Europe"
  ],
  "projects": [],
  "regions": [
    "Europe",
    "Western Europe",
    "Iran"
  ],
  "topics": [
    "EU"
  ]
}

In The Media

Carnegie Europe

Europe’s Open-Border Dilemma: Is Schengen a Success?

Europe’s Schengen zone, which allows Europeans to travel freely across the continent, is turning thirty. Faced with a major migration crisis, can the system survive?

By Marc Pierini

Published on May 27, 2015

Source: Euronews

Speaking to Euronews’ On the Frontline, Marc Pierini was asked to comment on the threats facing the Schengen zone. He was joined by Sergio Carrera from the Centre for European Policy Studies (CEPS) and Viviane Reding, Member of the European Parliament and former Vice-President of the European Commission.

This broadcast was originally aired on Euronews.

About the Author

Marc Pierini

Senior Fellow, Carnegie Europe

Pierini is a senior fellow at Carnegie Europe, where his research focuses on developments in the Middle East and Turkey from a European perspective.

Recent Work

Commentary
The Iran War’s Dangerous Fallout for Europe
- Marc Pierini
Other
Unpacking Trump’s National Security Strategy
- +18
  James M. Acton, Saskia Brechenmacher, Cecily Brewer, …

EU Europe Western Europe Iran

Carnegie India does not take institutional positions on public policy issues; the views represented herein are those of the author(s) and do not necessarily reflect the views of Carnegie, its staff, or its trustees.

More Work from Carnegie India

Article
Can Geopolitical Alignment Seal the India-EU FTA?
This article argues that the geopolitical circumstances have never been more conducive, not merely for the early conclusion of the free trade agreement (FTA) between India and the EU, but also for crafting a substantive and comprehensive strategic partnership.
Mohan Kumar
Commentary
How WHO’s “One Health” Program Can Help India Tackle Monkeypox
With monkeypox being declared a global health emergency, the WHO approach is an innovative and effective way to curb outbreaks of zoonotic diseases.
Shruti Sharma
Paper
Lessons from the Coronavirus Pandemic: Leveraging Biotechnology to Tackle Infectious Diseases in India
In India, biotechnology has played an important role in helping stakeholders in academia, industry, and government develop new pandemic-related technology, from test kits to respiratory devices. But these biotechnology advancements can go further to strengthen India’s public health capacity.
Shruti Sharma
Commentary
Combating Vaccine Hesitancy in India
Unless the government can up its communications game, anti-vax movements could prolong India’s pandemic effects.
Shruti Sharma
Commentary
How Should Countries Study Viruses Safely?
The uncertain origin of the coronavirus has focused attention on gain-of-function research—studying viruses to learn how they spread. How can countries work together to ensure stringent safety standards?
Shruti Sharma

More Work from Carnegie India

Article

Can Geopolitical Alignment Seal the India-EU FTA?

This article argues that the geopolitical circumstances have never been more conducive, not merely for the early conclusion of the free trade agreement (FTA) between India and the EU, but also for crafting a substantive and comprehensive strategic partnership.

Mohan Kumar

Commentary

How WHO’s “One Health” Program Can Help India Tackle Monkeypox

With monkeypox being declared a global health emergency, the WHO approach is an innovative and effective way to curb outbreaks of zoonotic diseases.

Shruti Sharma

Paper

Lessons from the Coronavirus Pandemic: Leveraging Biotechnology to Tackle Infectious Diseases in India

In India, biotechnology has played an important role in helping stakeholders in academia, industry, and government develop new pandemic-related technology, from test kits to respiratory devices. But these biotechnology advancements can go further to strengthen India’s public health capacity.

Shruti Sharma

Commentary

Combating Vaccine Hesitancy in India

Unless the government can up its communications game, anti-vax movements could prolong India’s pandemic effects.

Shruti Sharma

Commentary

How Should Countries Study Viruses Safely?

The uncertain origin of the coronavirus has focused attention on gain-of-function research—studying viruses to learn how they spread. How can countries work together to ensure stringent safety standards?

Shruti Sharma